Associations Among Disease Conditions, Bone Mineral Density, and Prevalent Vertebral Deformities in Men and Women 50 Years of Age and Older: Cross‐Sectional Results From the Canadian Multicentre Osteoporosis Study
暂无分享,去创建一个
S. Kirkland | G. Ioannidis | A. Papaioannou | A. Tenenhouse | C. Joyce | C. Berger | T. Anastassiades | D. Hanley | W. Olszynski | L. Pickard | W. Olszynski | L. Joseph | J.P. Brown | J. Prior | T. Murray | S. Jackson | S. Poliquin | J. Adachi | Stuart Jackson | David A. Hanley | Jerilynn C. Prior | Jacques P. Brown | Alexandra Papaioannou | Jonathan D. Adachi | Tassos Anastassiades | T. Murray | Susan Kirkland
[1] R. Nespoli,et al. A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content. , 1998, The Journal of urology.
[2] H. Yki-Järvinen. Pathogenesis of non-insulin-dependent diabetes mellitus , 1994, The Lancet.
[3] S. A. Jackson,et al. Vertebral Fracture Definition from Population-Based Data: Preliminary Results from the Canadian Multicenter Osteoporosis Study (CaMos) , 2000, Osteoporosis International.
[4] J. Hopper,et al. Risk factors for osteoporosis , 1989, Osteoporosis International.
[5] Breslau Na. Pathogenesis and management of hypercalciuric nephrolithiasis. , 1994 .
[6] Jacques P. Brown,et al. Research Notes: The Canadian Multicentre Osteoporosis Study (CaMos): Background, Rationale, Methods , 1999, Canadian Journal on Aging / La Revue canadienne du vieillissement.
[7] K. Birkeland,et al. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. , 1993, The Journal of clinical endocrinology and metabolism.
[8] M. Evans,et al. Clinical practice guidelines for the diagnosis and management of osteoporosis , 1997 .
[9] P. Wolf,et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. , 1994, American journal of public health.
[10] S. Silverman,et al. Deterioration in Quality of Life Following Hip Fracture: A Prospective Study , 2000, Osteoporosis International.
[11] K. Khaw,et al. Sex hormones and bone mineral density in elderly men. , 1993, Bone and mineral.
[12] S. Cummings,et al. Older women with diabetes have an increased risk of fracture: a prospective study. , 2001, The Journal of clinical endocrinology and metabolism.
[13] A. Hofman,et al. Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study , 1995, Annals of Internal Medicine.
[14] S. Cummings,et al. Factors Associated with Appendicular Bone Mass in Older Women , 1993, Annals of Internal Medicine.
[15] J. Casez,et al. Low bone mass in idiopathic renal stone formers: Magnitude and significance , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] K. Lau,et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. , 1990, The Journal of clinical endocrinology and metabolism.
[17] T. Clemens,et al. Bone mineral density in women with type II diabetes mellitus , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] N. Breslau. Pathogenesis and management of hypercalciuric nephrolithiasis. , 1994, Mineral and electrolyte metabolism.
[19] R. Lindsay. Why do oestrogens prevent bone loss? , 1991, Bailliere's clinical obstetrics and gynaecology.
[20] G. Hortobagyi,et al. Pilot study of bone mineral density in breast cancer patients treated with adjuvant chemotherapy. , 1998, Cancer investigation.
[21] T. Pepersack,et al. Low calcium diet in idiopathic urolithiasis: a risk factor for osteopenia as great as in primary hyperparathyroidism. , 1990, British journal of urology.
[22] R. Lindsay. 5 Why do oestrogens prevent bone loss , 1991 .
[23] I. Heilberg,et al. Bone disease in calcium stone forming patients. , 1994, Clinical nephrology.
[24] D. Bauer,et al. Axial Bone Mass in Older Women , 1996, Annals of Internal Medicine.
[25] P. Delmas,et al. Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] C. Cooper,et al. Health‐Related Quality of Life in Postmenopausal Women With Low BMD With or Without Prevalent Vertebral Fractures , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[27] Lawrence Joseph,et al. Multiple Imputation to Account for Missing Data in a Survey: Estimating the Prevalence of Osteoporosis , 2002, Epidemiology.
[28] B. Reed,et al. Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. , 1999, The Journal of clinical endocrinology and metabolism.
[29] L. Kuller,et al. Determinants of bone mineral density in older men , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.